Meds A-Z
Carprofen
Detailed information about Carprofen
Pet Owner Quick Guide
Start here: what this medicine is for, what it does, and when it's usually needed.
Usually used for:
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries
What it does:
NSAID used for pain and inflammation (commonly osteoarthritis and post-operative pain in dogs).
When it's needed:
Avoid combining with other NSAIDs or corticosteroids. Use caution with kidney/liver disease or GI ulcer history.
Call your vet sooner if you notice:
- Avoid combining with other NSAIDs or corticosteroids. Use caution with kidney/liver disease or GI ulcer history.
Commonly reported reactions:
- (2 reports)
- (1 reports)
- (1 reports)
What to ask your vet today:
- Is this medicine the right fit for my pet’s current symptoms?
- Which warning signs mean I should call back right away?
- How should I handle missed doses or refusal to take the medicine?
Carprofen
Drug type: Generic ingredient • Branded profile • FDA branded products available
Species: Dog
Manufacturer: Elanco
Quick Facts
Official label facts first, then secondary summaries. Marketing content is separated below.
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/200575 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/200366 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Medication usage source
Warnings / Contraindications
Avoid combining with other NSAIDs or corticosteroids. Use caution with kidney/liver disease or GI ulcer history.
- High: Avoid combining with other NSAIDs or corticosteroids. Use caution with kidney/liver disease or GI ulcer history.
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Contraindication source
Adverse Reactions
Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.
Tap or hover a reaction to see what it means in plain language.
Most Reported Reactions
| Reaction | Cases | Species | Serious cases |
|---|---|---|---|
| 2 | Cat, Dog | 2 | |
| 1 | Cat | 1 | |
| 1 | Dog | 1 | |
| 1 | Dog | 1 | |
| 1 | Cat | 1 | |
| 1 | Dog | 1 | |
| 1 | Dog | 1 | |
| 1 | Dog | 1 |
Species coverage: Cat (16) Dog (16)
View detailed reaction table
| Reaction | Species | Seriousness | Frequency | Reports |
|---|---|---|---|---|
| Cat | Non-serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - |
- https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2025-US-050545
Storage & Handling
Store at room temperature in a dry place.
Documents
Official label facts are separated from secondary summaries.
Official documents: 80 • Secondary summaries: 0
- UCM433785.pdf · FOI
- Carprofen Chewable Tablets · SPL
- ucm059301.pdf · FOI
- ucm059299.pdf · FOI
- UCM050400.pdf · Labeling
- UCM050400.pdf · Labeling
- Novox® Caplets · SPL
- Carprofen Caplets · SPL
- FOI Summary oA 200-767 Approved January 12, 2024.pdf · FOI
- A-200767-C-0019-NL-AA_CIS.pdf · Labeling
- A-200767-C-0019-NL-AA_PI.pdf · Labeling
- Carprofen Tablets · SPL
- UCM443086.pdf · FOI
- Carprofen Flavored Tablets · SPL
- VetprofenInserts.pdf · Labeling
- VetprofenCIS 1.pdf · Labeling
- Vetprofen™ · SPL
- FOI Summary oA 200-762 Approved December 22, 2023.pdf · FOI
- Carofenvet_50mg_package_insert_v0125.pdf · Labeling
- Carofenvet™ · SPL
- FOI Summary oA 200-687 Approved July 29, 2020.pdf · FOI
- A-200687 client information sheet.pdf · Labeling
- A-200687-R-0012-CS-AA_PI.pdf · Labeling
- Carprofen Chewable Tablets · SPL
- FOI Summary oA 200-777 Approved April 10, 2024.pdf · FOI
- A-200777-C-0015-NL-AA_PI.pdf · Labeling
- Carprofen · SPL
- FOI Summary oA 200-706 Approved June 28, 2021.pdf · FOI
- A-200706-C-0023-NL-AA_CIS.pdf · Labeling
- A-200706-C-0023-NL-AA_PI.pdf · Labeling
- CARPROFEN Chewable Tablets · SPL
- FOI Summary oA 200-795 Approved September 5, 2024.pdf · FOI
- CARPROFEN Soft Chewable Tablets · SPL
- FOI Summary oA 200-739 Approved February 2, 2023.pdf · FOI
- A-200739-C-0001-NL-AA_CIS.pdf · Labeling
- A-200739-C-0001-NL-AA_PI.pdf · Labeling
- Carprofen · SPL
- UCM167678.pdf · FOI
- A-200498-C-0099-NL-AA_CIS.pdf · Labeling
- A-200498-C-0099-NL-AA_PI.pdf · Labeling
- CARPRIEVE® · SPL
- FOI Summary oA 200-732 Approved January 5, 2023.pdf · FOI
- Carprofen Tablets · SPL
- UCM408901.pdf · FOI
- A-200520-C-0044-NL-AA_PI.pdf · Labeling
- Carprieve® Injection · SPL
- ucm117623.pdf · FOI
- ucm117619.pdf · FOI
- ucm117613.pdf · FOI
- N-141199-R-0060-CS-AA_PI.pdf · Labeling
- Rimadyl® Sterile Injectable Solution · SPL
- FOI Summary oA 200-703 Approved July 7, 2021.pdf · FOI
- A-200703-A-0000-OT-AA_PI.pdf · Labeling
- Carprofen Tablets · SPL
- FOI Summary oA 200-681 Approved August 4, 2020.pdf · FOI
- A-200681-A-0000-OT-AA_PI.pdf · Labeling
- Carprofen Tablets · SPL
- FOI Summary oA 200-490 Approved October 1, 2018.pdf · FOI
- Carprofen · SPL
- UCM218511.pdf · FOI
- ucm116543.pdf · FOI
- UCM460231.pdf · FOI
- N-141053-C-0137-NL-AA_CIS.pdf · Labeling
- N-141053-C-0137-NL-AA_PI.pdf · Labeling
- Rimadyl® Caplets · SPL
- UCM218513.pdf · FOI
- ucm117153.pdf · FOI
- ucm117151.pdf · FOI
- N-141111-C-0098-NL-AA_CIS.pdf · Labeling
- N-141111-C-0098-NL-AA_PI.pdf · Labeling
- Rimadyl® Chewable Tablets · SPL
- UCM421902.pdf · FOI
- ANADA 200522 package Insert_Redacted.pdf · Labeling
- Carprofen Sterile Injectable Solution · SPL
- FOI Summary oA 200-595 Approved April 28, 2017.pdf · FOI
- Carprieve® Chewable Tablets · SPL
- FOI Summary oA 200-593 Approved April 19, 2017.pdf · FOI
- Carprofen Injection · SPL
- UCM367497.pdf · FOI
- quellin® · SPL
No source yet.
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1251 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2346/Carprofen%20Chewable%20Tablets · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1120 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1119 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/41 · document · Labeling
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/42 · document · Labeling
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/136/Novox%C2%AE%20Caplets · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/135/Carprofen%20Caplets · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/14968 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadLabeling/1738 · document · Labeling
Promotional Materials (Marketing)
This content is marketing material and not clinical guidance.
No marketing assets are linked yet.
No source yet.
Technical appendix (vet reference)
Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.
At a Glance
Quick facts and links to official labeling and safety signals.
- Medication catalog: Source PetWisePlus | Refreshed Feb 12, 2026, 7:40 PM UTC
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Feb 16, 2026, 11:01 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Feb 9, 2026, 3:19 AM UTC
Counseling and Monitoring Highlights
Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.
- Avoid combining with other NSAIDs or corticosteroids. Use caution with kidney/liver disease or GI ulcer history. (Contraindication, High)
Identifiers & Packages
Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.
| Package NDC | Product NDC | Form / Route | Status |
|---|---|---|---|
| 11695-6935-1 | 11695 | - | |
| 11695-6935-2 | 11695 | - | |
| 11695-7001-1 | 11695 | - | |
| 11695-7001-2 | 11695 | - | |
| 11695-7001-3 | 11695 | - | |
| 11695-7002-1 | 11695 | - | |
| 11695-7002-2 | 11695 | - | |
| 11695-7002-3 | 11695 | - | |
| 11695-7003-1 | 11695 | - | |
| 11695-7003-2 | 11695 | - | |
| 11695-7003-3 | 11695 | - | |
| 11695-7004-0 | 11695 | - | |
| 11695-7004-1 | 11695 | - | |
| 11695-7004-2 | 11695 | - | |
| 11695-7005-0 | 11695 | - | |
| 11695-7005-1 | 11695 | - | |
| 11695-7005-2 | 11695 | - | |
| 11695-7006-0 | 11695 | - | |
| 11695-7006-1 | 11695 | - | |
| 11695-7006-2 | 11695 | - |
Enriched Documents
Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.
-
UCM433785.pdf
• FOI summary • Official
• Aug. 26, 2025
FDA FOI summary for application 200575
-
UCM050400.pdf
• Official label • Official
• Aug. 26, 2025
FDA official labeling for application 200366
-
UCM050400.pdf
• Official label • Official
• Aug. 26, 2025
FDA official labeling for application 200366
-
ucm059299.pdf
• FOI summary • Official
• Aug. 26, 2025
FDA FOI summary for application 200366
-
ucm059301.pdf
• FOI summary • Official
• Aug. 26, 2025
FDA FOI summary for application 200366
-
A-200767-C-0019-NL-AA_PI.pdf
• Official label • Official
• March 20, 2025
FDA official labeling for application 200767
-
A-200767-C-0019-NL-AA_CIS.pdf
• Official label • Official
• March 20, 2025
FDA official labeling for application 200767
-
FOI Summary oA 200-767 Approved January 12, 2024.pdf
• FOI summary • Official
• March 20, 2025
FDA FOI summary for application 200767
-
UCM443086.pdf
• FOI summary • Official
• Feb. 24, 2025
FDA FOI summary for application 200578
-
VetprofenCIS 1.pdf
• Official label • Official
• Feb. 24, 2025
FDA official labeling for application 200397
-
VetprofenInserts.pdf
• Official label • Official
• Feb. 24, 2025
FDA official labeling for application 200397
-
Carofenvet_50mg_package_insert_v0125.pdf
• Official label • Official
• Feb. 5, 2025
FDA official labeling for application 200762
-
FOI Summary oA 200-762 Approved December 22, 2023.pdf
• FOI summary • Official
• Feb. 5, 2025
FDA FOI summary for application 200762
-
A-200687-R-0012-CS-AA_PI.pdf
• Official label • Official
• Feb. 5, 2025
FDA official labeling for application 200687
-
A-200687 client information sheet.pdf
• Official label • Official
• Feb. 5, 2025
FDA official labeling for application 200687
-
FOI Summary oA 200-687 Approved July 29, 2020.pdf
• FOI summary • Official
• Feb. 5, 2025
FDA FOI summary for application 200687
-
A-200777-C-0015-NL-AA_PI.pdf
• Official label • Official
• Jan. 16, 2025
FDA official labeling for application 200777
-
FOI Summary oA 200-777 Approved April 10, 2024.pdf
• FOI summary • Official
• Jan. 16, 2025
FDA FOI summary for application 200777
-
A-200706-C-0023-NL-AA_PI.pdf
• Official label • Official
• Jan. 13, 2025
FDA official labeling for application 200706
-
A-200706-C-0023-NL-AA_CIS.pdf
• Official label • Official
• Jan. 13, 2025
FDA official labeling for application 200706
-
FOI Summary oA 200-706 Approved June 28, 2021.pdf
• FOI summary • Official
• Jan. 13, 2025
FDA FOI summary for application 200706
-
FOI Summary oA 200-795 Approved September 5, 2024.pdf
• FOI summary • Official
• Oct. 1, 2024
FDA FOI summary for application 200795
-
A-200739-C-0001-NL-AA_PI.pdf
• Official label • Official
• Aug. 17, 2023
FDA official labeling for application 200739
-
A-200739-C-0001-NL-AA_CIS.pdf
• Official label • Official
• Aug. 17, 2023
FDA official labeling for application 200739
-
FOI Summary oA 200-739 Approved February 2, 2023.pdf
• FOI summary • Official
• Aug. 17, 2023
FDA FOI summary for application 200739
-
A-200498-C-0099-NL-AA_PI.pdf
• Official label • Official
• April 20, 2023
FDA official labeling for application 200498
-
A-200498-C-0099-NL-AA_CIS.pdf
• Official label • Official
• April 20, 2023
FDA official labeling for application 200498
-
UCM167678.pdf
• FOI summary • Official
• April 20, 2023
FDA FOI summary for application 200498
-
FOI Summary oA 200-732 Approved January 5, 2023.pdf
• FOI summary • Official
• Feb. 1, 2023
FDA FOI summary for application 200732
-
A-200520-C-0044-NL-AA_PI.pdf
• Official label • Official
• Dec. 16, 2022
FDA official labeling for application 200520
-
UCM408901.pdf
• FOI summary • Official
• Dec. 16, 2022
FDA FOI summary for application 200520
-
N-141199-R-0060-CS-AA_PI.pdf
• Official label • Official
• March 21, 2022
FDA official labeling for application 141199
-
ucm117613.pdf
• FOI summary • Official
• March 21, 2022
FDA FOI summary for application 141199
-
ucm117619.pdf
• FOI summary • Official
• March 21, 2022
FDA FOI summary for application 141199
-
ucm117623.pdf
• FOI summary • Official
• March 21, 2022
FDA FOI summary for application 141199
-
A-200703-A-0000-OT-AA_PI.pdf
• Official label • Official
• Aug. 2, 2021
FDA official labeling for application 200703
-
FOI Summary oA 200-703 Approved July 7, 2021.pdf
• FOI summary • Official
• Aug. 2, 2021
FDA FOI summary for application 200703
-
A-200681-A-0000-OT-AA_PI.pdf
• Official label • Official
• Sept. 1, 2020
FDA official labeling for application 200681
-
FOI Summary oA 200-681 Approved August 4, 2020.pdf
• FOI summary • Official
• Sept. 1, 2020
FDA FOI summary for application 200681
-
FOI Summary oA 200-490 Approved October 1, 2018.pdf
• FOI summary • Official
• Oct. 1, 2019
FDA FOI summary for application 200490
Data Sources & Revision History
Every non-trivial field is expected to include provenance and update timestamps.
- overdose_info: Overdose can cause severe GI bleeding and kidney injury. Seek emergency veterinary care. (Clinical, 2026-02-12)
- storage_handling: Store at room temperature in a dry place. (Clinical, 2026-02-12)
- contraindications: Avoid combining with other NSAIDs or corticosteroids. Use caution with kidney/liver disease or GI ulcer history. (Official, 2026-02-12)
- side_effects: GI upset (vomiting/diarrhea), decreased appetite, lethargy. Rare: ulceration or liver enzyme elevations. (Official, 2026-02-12)
- usage: NSAID used for pain and inflammation (commonly osteoarthritis and post-operative pain in dogs). (Official, 2026-02-12)
- side_effects updated 2026-02-12 19:40 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-02-12 19:40 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-02-12 19:40 by etl_backfill • Backfilled from existing medication fields
FDA Products & Applications (Animal Drugs @ FDA)
Official sponsor/proprietary-name/application-status records linked by active ingredient.
| Product | Sponsor | Application | Status | Published |
|---|---|---|---|---|
|
Carprofen Chewable Tablets
RX
Carprofen
Scored Chewable Tablets
• Oral
|
Dechra Veterinary Products LLC | ANADA 200-575 | W | Aug 26, 2025 |
|
Novox® Caplets Carprofen Caplets
RX
Carprofen
Caplet
• Oral
|
Dechra Veterinary Products LLC | ANADA 200-366 | W | Aug 26, 2025 |
|
Carprofen Tablets
RX
Carprofen
Flavored Tablets
• Oral
|
Felix Pharmaceuticals Pvt. Ltd. | ANADA 200-767 | Approved | Mar 20, 2025 |
|
Carprofen Flavored Tablets
RX
Carprofen
Tablet
• Oral
|
Ajenat Pharmaceuticals LLC | ANADA 200-578 | Approved | Feb 24, 2025 |
|
Vetprofen™
RX
Carprofen
Caplet
• Oral
|
Ajenat Pharmaceuticals LLC | ANADA 200-397 | Approved | Feb 24, 2025 |
|
Carofenvet™
RX
Carprofen
Injectable Solution
• Subcutaneous
|
Cronus Pharma Specialities India Private Ltd. | ANADA 200-762 | Approved | Feb 5, 2025 |
|
Carprofen Chewable Tablets
RX
Carprofen
Chewable Tablets
• Oral
|
Cronus Pharma Specialities India Private Ltd. | ANADA 200-687 | Approved | Feb 5, 2025 |
|
Carprofen
RX
Carprofen
Injectable Solution
• Subcutaneous
|
Felix Pharmaceuticals Pvt. Ltd. | ANADA 200-777 | Approved | Jan 16, 2025 |
|
CARPROFEN Chewable Tablets
RX
Carprofen
Chewable Tablets
• Oral
|
Felix Pharmaceuticals Pvt. Ltd. | ANADA 200-706 | Approved | Jan 13, 2025 |
|
CARPROFEN Soft Chewable Tablets
RX
Carprofen
Chewable Tablets
• Oral
|
Felix Pharmaceuticals Pvt. Ltd. | ANADA 200-795 | Approved | Oct 1, 2024 |
|
Carprofen
RX
Carprofen
Chewable Tablets
• Oral
|
ZYVET AH, Inc. | ANADA 200-739 | Approved | Aug 17, 2023 |
|
CARPRIEVE®
RX
Carprofen
Tablet
• Oral
|
Norbrook Laboratories, Ltd. | ANADA 200-498 | Approved | Apr 20, 2023 |
|
Carprofen Tablets
RX
Carprofen
Caplet
• Oral
|
Felix Pharmaceuticals Pvt. Ltd. | ANADA 200-732 | Approved | Feb 1, 2023 |
|
Carprieve® Injection
RX
Carprofen
Injectable Solution
• Subcutaneous
|
Norbrook Laboratories, Ltd. | ANADA 200-520 | Approved | Dec 16, 2022 |
|
Rimadyl® Sterile Injectable Solution
RX
Carprofen
Liquid (Solution)
• Subcutaneous
|
Zoetis Inc. | NADA 141-199 | Approved | Mar 21, 2022 |
|
Carprofen Tablets
RX
Carprofen
Caplet
• Oral
|
Dechra Veterinary Products LLC | ANADA 200-703 | Approved | Aug 2, 2021 |
|
Carprofen Tablets
RX
Carprofen
Flavored Tablets
• Oral
|
Dechra Veterinary Products LLC | ANADA 200-681 | Approved | Sep 1, 2020 |
|
Carprofen
RX
Carprofen
Chewable Tablets
• Oral
|
Dechra Veterinary Products LLC | ANADA 200-490 | Approved | Oct 1, 2019 |
|
Rimadyl® Caplets
RX
Carprofen
Caplet
• Oral
|
Zoetis Inc. | NADA 141-053 | Approved | Aug 27, 2019 |
|
Rimadyl® Chewable Tablets
RX
Carprofen
Tablet (Chewable)
• Oral
|
Zoetis Inc. | NADA 141-111 | Approved | Jul 1, 2019 |
|
Carprofen Sterile Injectable Solution
RX
Carprofen
Injectable Solution
• Subcutaneous
|
Dechra Veterinary Products LLC | ANADA 200-522 | Approved | Jun 12, 2018 |
|
Carprieve® Chewable Tablets
RX
Carprofen
Chewable Tablets
• Oral
|
Norbrook Laboratories, Ltd. | ANADA 200-595 | Approved | May 1, 2017 |
|
Carprofen Injection
RX
Carprofen
Injectable Solution
• Subcutaneous
|
Accord Healthcare, Inc. | ANADA 200-593 | Approved | May 1, 2017 |
|
quellin®
RX
Carprofen
Soft Chewable Tablet
• Oral
|
Elanco US Inc. | ANADA 200-555 | Approved | Jun 1, 2016 |
Data source: FDA Animal Drugs @ FDA (public search export).
What It's For (FDA Label Highlights)
Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
2 milligram per pound (4.4 mg/kg) of body weight once daily or 1 milligram per pound twice daily.
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
The recommended dosage for subcutaneous administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as either 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily. For control of postoperative pain, administer approximately 2 hours before the procedure.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
The recommended dosage for oral administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily. For the control of postoperative pain, administer approximately 2 hours before the procedure. For scored tablets, dosage should be calculated in half-tablet increments.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
The recommended dosage for subcutaneous administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as either 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily. For control of postoperative pain, administer approximately 2 hours before procedure.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
The recommended dosage for oral administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily. For the control of postoperative pain, administer approximately 2 hours before the procedure. For scored tablets, dosage should be calculated in half-tablet increments.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
The recommended dosage for oral administration to dogs is 2 mg/lb of body weight daily. The total daily dose may be administered as 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb twice daily. For the control of postoperative pain, administer approximately 2 hours before the procedure.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
The recommended dosage for oral administration to dogs is 2 mg/lb of body weight daily. The total daily dose may be administered as 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb twice daily. For the control of postoperative pain, administer approximately 2 hours before the procedure. Carprofen chewable tablets are scored and dosage should be calculated in half-tablet increments.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
The recommended dosage for oral administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily. For the control of postoperative pain, administer approximately 2 hours before the procedure.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
Federal law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
The recommended dosage for oral administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as 2 mg/lb of body weight daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily. For the control of postoperative pain, administer approximately 2 hours before the procedure.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
The recommended dosage for oral administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily. For the control of postoperative pain, administer approximately 2 hours before the procedure. Tablets are scored and dosage should be calculated in half-tablet increments.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue
and orthopedic surgeries in dogs.
The recommended dosage for oral administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily. For the control of postoperative pain, administer approximately 2 hours before the procedure. Tablets are scored and dosage should be calculated in half-tablet increments.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
The recommended dosage for oral administration to dogs is 2 mg/lb (4.4 mg/kg) of body weight daily. The total daily dose may be administered as 2 mg/lb of body weight once daily or divided and administered as 1 mg/lb (2.2 mg/kg) twice daily. For the control of postoperative pain, administer approximately 2 hours before the procedure. Tablets are scored and dosage should be calculated in half-tablet increments.
Federal Law restricts this drug to use by or on the order of a licensed veterinarian.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries.
2 mg/lb. (4.4 mg/kg) body weight once daily or 1 mg/lb. pound (2.2 mg/kg) body weight twice daily.
For use in dogs only. Do not use in cats. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For the control of postoperative pain, administer approximately 2 hours before the procedure.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Official Documents (FDA)
Direct links to FDA-hosted PDFs and SPL packages (when available).
-
FOI UCM433785.pdf
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries.
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm059301.pdf
Summary
This application provides for the additional indication for the control of postoperative pain associated with soft tissue and orthopedic surgeries. -
FOI ucm059299.pdf
Summary
For the relief of pain and inflammation associated with osteoarthritis in dogs. -
Labeling UCM050400.pdf
-
Labeling UCM050400.pdf
- Novox® Caplets (ZIP)
- Carprofen Caplets (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
-
Labeling A-200767-C-0019-NL-AA_CIS.pdf
-
Labeling A-200767-C-0019-NL-AA_PI.pdf
- Carprofen Tablets (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM443086.pdf
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
FDA page: Open in Animal Drugs @ FDA
-
Labeling VetprofenInserts.pdf
-
Labeling VetprofenCIS 1.pdf
- Vetprofen™ (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
- Carofenvet™ (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
-
Labeling A-200687-R-0012-CS-AA_PI.pdf
FDA page: Open in Animal Drugs @ FDA
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
-
Labeling A-200777-C-0015-NL-AA_PI.pdf
- Carprofen (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
-
Labeling A-200706-C-0023-NL-AA_CIS.pdf
-
Labeling A-200706-C-0023-NL-AA_PI.pdf
FDA page: Open in Animal Drugs @ FDA
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
FDA page: Open in Animal Drugs @ FDA
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
-
Labeling A-200739-C-0001-NL-AA_CIS.pdf
-
Labeling A-200739-C-0001-NL-AA_PI.pdf
- Carprofen (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM167678.pdf
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs. -
Labeling A-200498-C-0099-NL-AA_CIS.pdf
-
Labeling A-200498-C-0099-NL-AA_PI.pdf
- CARPRIEVE® (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
- Carprofen Tablets (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM408901.pdf
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs. -
Labeling A-200520-C-0044-NL-AA_PI.pdf
- Carprieve® Injection (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI ucm117623.pdf
Summary
This supplement to NADA 141-199 provides revisions to 21CFR 522.312 (2) Indications for Use. To add a claim for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs. -
FOI ucm117619.pdf
Summary
provides for the addition of a once daily administration of 2 mg/lb (4.4 mg/kg) of body weight in addition to a twice daily administration of 1 mg/lb (2.2 mg/kg) by subcutaneous injection. -
FOI ucm117613.pdf
Summary
Rimadyl® Injectable is indicated for the relief of pain and inflammation associated with -
Labeling N-141199-R-0060-CS-AA_PI.pdf
FDA page: Open in Animal Drugs @ FDA
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
-
Labeling A-200703-A-0000-OT-AA_PI.pdf
- Carprofen Tablets (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
-
Labeling A-200681-A-0000-OT-AA_PI.pdf
- Carprofen Tablets (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
- Carprofen (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM218511.pdf
Summary
To add a claim for the control of postoperative pain associated with soft tissue and orthopedic surgery in dogs. -
FOI ucm116543.pdf
Summary
This supplement provides for flexibility in administration of the total daily dose of Rimadyl® caplets. The drug may be administered orally at 2 milligrams per pound of body weight once daily or 1 milligram per pound of body weight twice daily. -
FOI UCM460231.pdf
Summary
RIMADYL® is indicated for the relief of pain and inflammation in dogs. RIMADYL was shown to be clinically effective for the reflief of signs associated with osteoarthritis in dogs. -
Labeling N-141053-C-0137-NL-AA_CIS.pdf
-
Labeling N-141053-C-0137-NL-AA_PI.pdf
- Rimadyl® Caplets (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM218513.pdf
Summary
For an additional claim for carprofen chewable tablets for the control of postoperative pain associated with soft tissue and orthopedic surgery in dogs. -
FOI ucm117153.pdf
Summary
This supplement provides for flexibility in administration of the total daily dose of Rimadyl® Chewable Tablets. The drug may be administered orally at 2 milligrams per pound of body weight once daily or 1 milligram per pound of body weight twice daily -
FOI ucm117151.pdf
Summary
Rimadyl® chewable tablets are indicated for the relief of pain and inflammation associated with osteoarthritis in dogs. -
Labeling N-141111-C-0098-NL-AA_CIS.pdf
-
Labeling N-141111-C-0098-NL-AA_PI.pdf
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM421902.pdf
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
FDA page: Open in Animal Drugs @ FDA
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
FDA page: Open in Animal Drugs @ FDA
-
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries.
- Carprofen Injection (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM367497.pdf
Summary
For the relief of pain and inflammation associated with osteoarthritis and for the control of postoperative pain associated with soft tissue and orthopedic surgeries in dogs.
- quellin® (ZIP)
FDA page: Open in Animal Drugs @ FDA
Usage
NSAID used for pain and inflammation (commonly osteoarthritis and post-operative pain in dogs).
Source: FDA Animal Drugs @ FDA • Reference
Contraindications
Avoid combining with other NSAIDs or corticosteroids. Use caution with kidney/liver disease or GI ulcer history.
Side Effects
GI upset (vomiting/diarrhea), decreased appetite, lethargy. Rare: ulceration or liver enzyme elevations.
Source: FDA openFDA • Reference
Top Reported Reactions (openFDA)
Aggregated reaction terms from FDA openFDA reports (not verified; does not prove causation).
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Adverse Event Case Summaries (openFDA)
These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.
Dog, Retriever - Golden, Male, 5 year, 36 kilogram • Drug: MSK, Tablet, chewable, Oral, Frequency: 1 per day • Reactions: Vomiting • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2025-US-056005
- Serious AE: No
- Treated For AE: No
- Sex: Male
- Age: 5.00 Year
- Weight: 36.000 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Tablet, chewable
- Frequency: 1 per day
Dog, Dog (unknown), Male, 14 year, 33.566 kilogram • Drug: MSK, Solution/drops, Unknown • Reactions: Hind limb paresis • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-055509
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 14.00 Year
- Weight: 33.566 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Solution/drops
Dog, Pit Bull, Female, 8.5 year, 23.587 kilogram • Drug: MSK, Tablet, Oral, Dose: 1 tablet per dose, Frequency: 1 per day • Reactions: Elevated alanine aminotransferase, Elevated aspartate aminotransferase, Elevated gamma-glutamyl transferase, Low thyroxine • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-055526
- Serious AE: Yes
- Treated For AE: No
- Sex: Female
- Age: 8.50 Year
- Weight: 23.587 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Tablet
- Dose: 1 tablet per dose
- Frequency: 1 per day
Dog, ['Dachshund - Standard Long-haired', 'Dog (unknown)'], Male, 12 year, 8.936 kilogram • Drug: MSK, Unknown • Reactions: Fever, Panting, Swollen limb, Localised pain NOS, Paralysis NOS • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-055637
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 12.00 Year
- Weight: 8.936 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
Dog, ['Shepherd Dog - German', 'Dog (unknown)'], Female, 2.5 year • Drug: MSK, Subcutaneous, Dose: 0.95 mL per animal • Reactions: Neutropenia, Eosinophilia, Lymphocytosis, Enamel disorder, Tooth disorder • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-055809
- Serious AE: Yes
- Treated For AE: No
- Sex: Female
- Age: 2.50 Year
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Subcutaneous
- Dose: 0.95 mL per animal
Cat, Cat (unknown), Female, 4.05 kilogram • Drug: MSK, Tablet, Oral, Dose: 50 Milligram per animal, Frequency: 24 per hour • Reactions: Hyperglycaemia • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-054116
- Serious AE: No
- Treated For AE: No
- Sex: Female
- Weight: 4.050 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Tablet
- Dose: 50 Milligram per animal
- Frequency: 24 per hour
Cat, Cat (other), Female • Drug: MSK, Injection, Unknown • Reactions: General illness, Death by euthanasia, Intentional misuse • Outcome: Euthanized
- Report ID: USA-USFDACVM-2025-US-050538
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Female
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Unknown
- Form: Injection
Cat, ['Cat (unknown)', 'Cat (unknown)'], Unknown, 9 kilogram • Drug: MSK, Tablet, chewable, Oral • Reactions: Dilated pupils, Accidental exposure • Outcome: Recovered/Normal
- Report ID: USA-USFDACVM-2025-US-050545
- Serious AE: No
- Treated For AE: No
- Sex: Unknown
- Weight: 9.000 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Oral
- Form: Tablet, chewable
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Overdose Information
Overdose can cause severe GI bleeding and kidney injury. Seek emergency veterinary care.
Storage & Handling
Store at room temperature in a dry place.
Share Your Thoughts
Let others know your experience or advice regarding this medication.
This medication has not been reviewed by a veterinarian yet.